The average age of men who get diagnosed is 67.

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

Study shows lower risk for multiple myeloma as well as pancreatic, prostate, breast and kidney cancers ...

Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...

Bayer today announced results from the ongoing global Phase I first-in-human, dose-escalation PAnTHa study (NCT06217822) evaluating the safety, tolerability and preliminary efficacy of ...